4-([1,1'-Biphenyl]-4-yl)-6-(3-bromo-5-(pyridin-3-yl)phenyl)-2-phenylpyrimidine

Catalog No. :
ACNUGA748
CAS No. :
2136352-10-6
Molecular Formula :
C33H22BrN3
Molecular Weight :
540.46

IUPAC Name:4-([1,1'-biphenyl]-4-yl)-6-(3-bromo-5-(pyridin-3-yl)phenyl)-2-phenylpyrimidine

4-([1,1'-Biphenyl]-4-yl)-6-(3-bromo-5-(pyridin-3-yl)phenyl)-2-phenylpyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-([1,1'-Biphenyl]-4-yl)-6-(3-bromo-5-(pyridin-3-yl)phenyl)-2-phenylpyrimidine
IUPAC Name4-([1,1'-biphenyl]-4-yl)-6-(3-bromo-5-(pyridin-3-yl)phenyl)-2-phenylpyrimidine
Molecular FormulaC33H22BrN3
Molecular Weight540.46
SMILESBrC1=CC(C2=CC(C3=CC=C(C4=CC=CC=C4)C=C3)=NC(C5=CC=CC=C5)=N2)=CC(C6=CC=CN=C6)=C1
InChI KeyWNFYOJAPKFOQFW-UHFFFAOYSA-N
SynonymTCOM93;Pyrimidine, 4-[1,1'-biphenyl]-4-yl-6-[3-bromo-5-(3-pyridinyl)phenyl]-2-phenyl-
CAS No.2136352-10-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNUGA748 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7 In Stock
  4. Then
  5. ACNUGA748 route product structure diagram
    ACNUGA7482136352-10-6
Inquiry

2. ACNUGA748 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACNUGA748 route product structure diagram
    ACNUGA7482136352-10-6
Inquiry

Comments (0)